ASLN - iQIYI Galapagos leads premarket losers' pack

Concord Medical Services Holdings (CCM) -40%.vTv Therapeutics (VTVT) -33% after azeliragon flunks in mid-stage alzheimer’s and diabetes study.BioLineRx (BLRX) -27% despite promising motixafortide data in pancreatic cancer.NanoVibronix (NAOV) -17%.Galapagos (GLPG) -15% after signing new commercialization pact for filgotinib.Xcel Brands (XELB) -14%.ASLAN Pharmaceuticals (ASLN) -10%.iQIYI (IQ) -9% on notes and ADSs offering.Mid-Con Energy Partners (MCEP) -9%.Penumbra (PEN) -8% after recalls JET 7 reperfusion catheter with xtra flex.Seelos Therapeutics (SEEL) -8%.Quad/Graphics (QUAD) -7%.Blonder Tongue Laboratories (BDR) -7%.Anchiano Therapeutics (ANCN) -6%.Contango Oil & Gas (MCF) -6%.Regulus Therapeutics (RGLS) -5%.

For further details see:

iQIYI, Galapagos leads premarket losers' pack